Merck & Co., Inc. $MRK Shares Sold by Spirepoint Private Client LLC
Spirepoint Private Client LLC cut its stake in Merck & Co., Inc. (NYSE:MRK – Free Report) by 85.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,994 shares of the company’s stock after selling 64,872 shares during the period. Spirepoint Private Client…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Allowing Medicare buy-ins would generate competition
The Hartford Expands Technology Team With New Office In Columbus, Ohio
Advisor News
- Wall Street CEOs warn Trump: Stop attacking the Fed and credit card industry
- Americans have ambitious financial resolutions for 2026
- FSI announces 2026 board of directors and executive committee members
- Tax implications under the One Big Beautiful Bill Act
- FPA launches FPAi Authority to support members with AI education and tools
More Advisor NewsAnnuity News
- Retirees drive demand for pension-like income amid $4T savings gap
- Reframing lifetime income as an essential part of retirement planning
- Integrity adds further scale with blockbuster acquisition of AIMCOR
- MetLife Declares First Quarter 2026 Common Stock Dividend
- Using annuities as a legacy tool: The ROP feature
More Annuity NewsHealth/Employee Benefits News
- Illinois uses state-run ACA exchange to extend deadline
- Fewer Americans sign up for Affordable Care Act health insurance as costs spike
- Deerhold and Windsor Strategy Partners Launch Solution that Enhances Network Analysis for Stop-Loss Carriers and MGUs
- Alameda County hospital system lays off hundreds of employees to counter federal cuts
- Detailing Medicare prescription drug coverage
More Health/Employee Benefits NewsLife Insurance News